RVL Pharmaceuticals (FRA:O1P) Days Sales Outstanding : 5.59 (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is RVL Pharmaceuticals Days Sales Outstanding?

RVL Pharmaceuticals's average Accounts Receivable for the three months ended in Jun. 2023 was €0.47 Mil. RVL Pharmaceuticals's Revenue for the three months ended in Jun. 2023 was €7.62 Mil. Hence, RVL Pharmaceuticals's Days Sales Outstanding for the three months ended in Jun. 2023 was 5.59.

The historical rank and industry rank for RVL Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

FRA:O1P' s Days Sales Outstanding Range Over the Past 10 Years
Min: 6.95 Med: 65.68 Max: 309.38
Current: 8.22

During the past 7 years, RVL Pharmaceuticals's highest Days Sales Outstanding was 309.38. The lowest was 6.95. And the median was 65.68.

FRA:O1P's Days Sales Outstanding is ranked better than
95.83% of 887 companies
in the Biotechnology industry
Industry Median: 72.43 vs FRA:O1P: 8.22

RVL Pharmaceuticals's Days Sales Outstanding increased from Jun. 2022 (0.00) to Jun. 2023 (5.59).

RVL Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for RVL Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RVL Pharmaceuticals Days Sales Outstanding Chart

RVL Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

64.09

75.29

336.78

60.99

6.95

RVL Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Days Sales Outstanding	Get a 7-Day Free Trial															-	12.46	11.22	4.99	5.59

Competitive Comparison of RVL Pharmaceuticals's Days Sales Outstanding

For the Biotechnology subindustry, RVL Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RVL Pharmaceuticals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RVL Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where RVL Pharmaceuticals's Days Sales Outstanding falls into.

RVL Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

RVL Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (0	+	0.894)	/	1 )	/	46.937	*	365
=	0.894					/	46.937	*	365
=	6.95

RVL Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0.008	+	0.926)	/	2 )	/	7.622	*	365 / 4
=	0.467					/	7.622	*	365 / 4
=	5.59

RVL Pharmaceuticals (FRA:O1P) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

RVL Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of RVL Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

RVL Pharmaceuticals (FRA:O1P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RVL Pharmaceuticals PLC (FRA:O1P) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

RVLPQ:USA

Address

400 Crossing Boulevard, Bridgewater, NJ, USA, 08807

Website

https://www.rvlpharma.com

RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.

RVL Pharmaceuticals (FRA:O1P) Headlines

No Headlines